ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

1.175 -0.005 (-0.42%)

Streaming Delayed Price Updated: 12:07 PM EST, Feb 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	272,784
Open	1.180
Bid (Size)	1.170 (2,600)
Ask (Size)	1.180 (5,800)
Prev. Close	1.180
Today's Range	1.170 - 1.220
52wk Range	0.9999 - 2.680
Shares Outstanding	140,759,276
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

February 17, 2026

From Heron Therapeutics, Inc.

Via GlobeNewswire

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

January 09, 2026

From Heron Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	-6.7%	-6.7%
1 Month	-17.3%	-17.3%
3 Month	+4.0%	+4.0%
6 Month	-14.9%	-14.9%
1 Year	-33.6%	-33.6%

More News

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

December 04, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Heron Therapeutics Inc. (NASDAQ: HRTX) Near the Top of Equities by Percentage Gain on 4/23

April 23, 2024

Via Investor Brand Network

Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates ↗

November 04, 2025

Via Chartmill

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

November 04, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

October 29, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 21, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 08, 2025

Via Benzinga

These stocks are moving in today's session ↗

August 08, 2025

Via Chartmill

Traders are paying attention to the gapping stocks in Friday's session. ↗

August 08, 2025

Via Chartmill

Heron (HRTX) Q2 Acute Care Jumps 56% ↗

August 08, 2025

Via The Motley Fool

This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

June 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 04, 2024

Via Benzinga

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

December 04, 2024

Via Benzinga

Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday ↗

November 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

HRTX Stock Earnings: Heron Therapeutics Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

Via InvestorPlace

Top 3 Health Care Stocks That May Crash In May ↗

May 24, 2024

Via Benzinga

HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

Via InvestorPlace

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 23, 2024

Via Benzinga

Frequently Asked Questions

Is Heron Therapeutics, Inc. - Common Stock publicly traded?

Yes, Heron Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Heron Therapeutics, Inc. - Common Stock trade on?

Heron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Heron Therapeutics, Inc. - Common Stock?

The ticker symbol for Heron Therapeutics, Inc. - Common Stock is HRTX on the Nasdaq Stock Market

What is the current price of Heron Therapeutics, Inc. - Common Stock?

The current price of Heron Therapeutics, Inc. - Common Stock is 1.175

When was Heron Therapeutics, Inc. - Common Stock last traded?

The last trade of Heron Therapeutics, Inc. - Common Stock was at 02/23/26 12:07 PM ET

What is the market capitalization of Heron Therapeutics, Inc. - Common Stock?

The market capitalization of Heron Therapeutics, Inc. - Common Stock is 165.39M

How many shares of Heron Therapeutics, Inc. - Common Stock are outstanding?

Heron Therapeutics, Inc. - Common Stock has 165M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.